In the ongoing study, increased IL-17 in the COPD group and decrease in the AK-7-administered group suggest the role of IL-17 in controlling the release of IL-6 and TNF-α, thereby modulating inflammation. Here, TNF is linked to chronic obstructive pulmonary disease.